No profile data available.
Halberd Corporation (HALB) is a healthcare company in the nutritional and natural health products industry, based in Jackson Center, United States.
It reported revenue of $2,725 for fiscal year 2023, down 66.0% from fiscal year 2022, and net income of -$454,072. In Q4 2022 (the quarter ended July 31, 2022) revenue was $2,137. Its market capitalization was $919,494 as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended July 31, 2023; market data as of October 9, 2026.
Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases.
Halberd reported $2,725 in revenue for fiscal year 2023, down 66.0% from $8,020 in fiscal year 2022. In Q4 2022 revenue was $2,137.
$919,494 as of October 9, 2026.
Listed companies of a similar size in the same industry (nutritional and natural health products) include Agape ATP Corporation (ATPC), Acro Biomedical Co., Ltd. (ACBM), Herborium Group, Inc. (HBRM), Kaya Holdings, Inc. (KAYS).